Axon Biogenics Limited - Company Profile

It is a chemicals public limited company based in Delhi, Delhi, India, established in 1999.
1999 Delhi, Delhi, India Struck Off
Last Updated:
Access Report
About Axon Biogenics Limited

Axon Biogenics Limited, a struck off public limited company, was established on 06 May 1999 in Delhi, Delhi, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24239DL1999PLC099637. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.50 M.

Its leadership includes Arun Adlakha (Director), Vandana Adlakha Sapra (Director), Tarun Adlakha (Director). Its latest AGM occurred on 30 September 2014, with the balance sheet filed on 31 March 2014. It is based at 232Nagia Lake Appartment Paschim Vihar Piragarhi, Delhi, Delhi, 110087.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239DL1999PLC099637

  • Registration Number

    099637

  • Incorporation Date

    06 May 1999

  • Authorized Capital

    ₹1.50 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 1.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 26 Year, 9 Months
  • Last Filing with ROC 31 Mar 2014
Company report

Axon Biogenics Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Axon Biogenics Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Axon Biogenics Limited?
Current Directors
Name Designation Appointment Date Status
Arun Adlakha Director 20 Aug 1999 Current
Vandana Adlakha Sapra Director 20 Aug 1999 Current
Tarun Adlakha Director 06 May 1999 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Axon Biogenics.

Enhance accessibility to Axon Biogenics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Axon Biogenics revenue growth over time
Axon Biogenics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Axon Biogenics?

Unlock access to Axon Biogenics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Axon Biogenics?

Unlock and access historical data on people associated with Axon Biogenics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Axon Biogenics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Axon Biogenics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Axon Biogenics
Recent Activity within the Organization
  • Annual General Meeting

    The activity Axon Biogenics Limited last Annual general meeting of members was held on 30 Sep 2014 as per latest MCA records. was completed.

  • Balance Sheet

    Axon Biogenics Limited has filed its annual Financial statements for the year ended 31 Mar 2014 with Roc Delhi. was recorded as a recent event.

  • Director Appointment

    The activity Arun Adlakha was appointed as a Director was appointed as a Director on 20 Aug 1999 & has been associated with this company since 26 years 6 months . was completed.

  • Director Appointment

    Vandana Adlakha Sapra was appointed as a Director was appointed as a Director on 20 Aug 1999 & has been associated with this company since 26 years 6 months . was recorded as a recent event.

  • Director Appointment

    Progress on Tarun Adlakha was appointed as a Director was appointed as a Director on 06 May 1999 & has been associated with this company since 26 years 9 months . was documented.

  • Company Incorporation

    The activity Axon Biogenics Limited was registered on 06 May 1999 with Roc Delhi & aged 26 years 9 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Axon Biogenics Limited?

The CIN of Axon Biogenics Limited is U24239DL1999PLC099637.

Where is Axon Biogenics Limited headquartered?

Axon Biogenics Limited is headquartered at 232Nagia Lake Appartment Paschim Vihar Piragarhi, Delhi, Delhi, 110087.

When was Axon Biogenics Limited incorporated?

Axon Biogenics Limited was incorporated on 06 May 1999.

Who are the current directors of Axon Biogenics Limited?

The current directors of Axon Biogenics Limited are

What is the primary industry of Axon Biogenics Limited?

The primary industry of Axon Biogenics Limited is Chemicals.

Is Axon Biogenics Limited a listed company?

Axon Biogenics Limited is unlisted.

What is the capital structure of Axon Biogenics Limited?

The authorized capital of Axon Biogenics Limited is ₹1.50 M, and the paid-up capital is ₹0.50 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available